Vistagen Therapeutics, Inc. (VTGN) Form 10-Q Quarterly Reports
Vistagen Therapeutics, Inc. (VTGN) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: VTGN
CIK: 1411685
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 03/31
State: NV
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 3/31/2025 12:00:00 AM
Lead Engagement PartnerCaroline Reid
Audit LocationSan Francisco, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-09 | 2026-10-07 | 8-K | 0001628280-26-065559 | View SEC Doc Filr Page |
| 8-K | 2026-09-25 | 2026-09-25 | 8-K | 0001628280-26-063510 | View SEC Doc Filr Page |
| 8-K | 2026-09-24 | 2026-09-24 | 8-K | 0001628280-26-063316 | View SEC Doc Filr Page |
| 8-K | 2026-09-22 | 2026-09-22 | 8-K | 0001628280-26-063046 | View SEC Doc Filr Page |
| 8-K | 2026-09-11 | 2026-09-10 | 8-K | 0001628280-26-061445 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000947871-26-000804 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001193125-26-352371 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001628280-26-057116 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001831942-26-000032 | View SEC Doc Filr Page |
| 8-K | 2026-08-14 | 2026-08-14 | 8-K | 0001628280-26-056953 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001628280-26-054341 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-04 | 8-K | 0001628280-26-053304 | View SEC Doc Filr Page |
| DEFA14A | 2026-07-31 | — | DEFA14A | 0001628280-26-051406 | View SEC Doc Filr Page |
| DEF 14A | 2026-07-31 | 2026-07-31 | DEF 14A | 0001628280-26-051404 | View SEC Doc Filr Page |
| 4 | 2026-07-31 | 2026-07-29 | 4 Filing | 0001911501-26-000006 | View SEC Doc Filr Page |
| 3 | 2026-07-31 | 2026-07-29 | 3 Filing | 0001911501-26-000004 | View SEC Doc Filr Page |
| 8-K | 2026-07-31 | 2026-07-29 | 8-K | 0001628280-26-051251 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | 4 Filing | 0001924908-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | 4 Filing | 0001794362-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | 4 Filing | 0001412071-26-000006 | View SEC Doc Filr Page |
| 8-K | 2026-06-30 | 2026-06-30 | 8-K | 0001628280-26-046143 | View SEC Doc Filr Page |
| 8-K | 2026-06-17 | 2026-06-16 | 8-K | 0001628280-26-043989 | View SEC Doc Filr Page |
| 10-K | 2026-06-15 | 2026-03-31 | 10-K | 0001628280-26-043271 | View SEC Doc Filr Page |
| 8-K | 2026-06-15 | 2026-06-15 | 8-K | 0001628280-26-043232 | View SEC Doc Filr Page |
| 8-K | 2026-06-09 | 2026-06-09 | 8-K | 0001628280-26-041962 | View SEC Doc Filr Page |